A new HLA-DRB1 allele: DRB1*0343

Area of Science:

• Immunogenetics
• Molecular biology

Background:

• The Human Leukocyte Antigen (HLA) system plays a crucial role in immune response.
• Polymorphisms within HLA genes, particularly HLA-DRB1, are associated with various autoimmune diseases.
• Accurate HLA typing is essential for transplantation and disease association studies.

Purpose of the Study:

• To report the discovery and characterization of a new HLA-DRB1 allele, designated HLA-DRB1*0343.
• To detail the specific genetic and amino acid differences between HLA-DRB1*0343 and a closely related allele, HLA-DRB1*0330.

Main Methods:

• Nucleotide sequencing of the relevant HLA-DRB1 gene region.
• Bioinformatic analysis to identify novel alleles and compare them to known sequences.
• Amino acid sequence comparison to determine the impact of nucleotide variations.

Main Results:

• Identification of a novel HLA-DRB1 allele, HLA-DRB1*0343.
• HLA-DRB1*0343 differs from HLA-DRB1*0330 by a single nucleotide substitution (Guanine to Cytosine) at a specific position.
• This nucleotide change results in an amino acid alteration at position 38, changing Valine to Leucine.

Conclusions:

• The discovery of HLA-DRB1*0343 expands the known repertoire of HLA-DRB1 alleles.
• The single amino acid difference between *0343 and *0330 may have implications for peptide binding and T-cell recognition.
• Further studies are warranted to investigate the potential functional and clinical significance of this new allele.